Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice ...

A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into functional ones. However, the process carries a small chance of inserting ...

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

The White House is clamping down on pharma’s ability to buy new molecules from Chinese biotechs; Sanofi, Merck and others ...

Jesse Gelsinger died after receiving a gene therapy treatment to treat a liver disease. The death sparked an investigation ...

First commercially available cell culture solution for HEK293 cells and perfusion - optimized for high cell density (HCD), ...

The indication has been expanded to include use in newborns and allows patients and caregivers to apply the treatment at home ...

Construction has begun on a new centre for gene and cell therapy in the German capital, Berlin. The "Translation Centre" will ...

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.